– Therabody, líder mundial en tecnología de bienestar, se defiende de la reciente demanda por infracción de patente presentada por Hyperice Como principal propietario de patentes de percusión y fuerza impulsora detrás de muchas de las innovaciones de bienestar actuales, Therabody se defenderá enérgicamente contra la reciente demanda por infracción de patente presentada por Hyperice… Continue reading Therabody se defiende de la demanda por infracción de patente presentada por Hyperice
Category: Newswire
MAPS Public Benefit Corporation Announces Oversubscribed Series A Financing and Renames to Lykos Therapeutics
Funding comes from mission-aligned and institutional investors to support regulatory and pre-launch activities for investigational MDMA-assisted therapy for post-traumatic stress disorder (“PTSD”) Company rebrands and changes name to reflect its new stage of focus—the integration of the potential first psychedelic-assisted therapy into the healthcare system if approved by FDA SAN JOSE, Calif., Jan. 5, 2024… Continue reading MAPS Public Benefit Corporation Announces Oversubscribed Series A Financing and Renames to Lykos Therapeutics
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
LEXINGTON, Mass., Jan. 5, 2024 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on January 2, 2024, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total… Continue reading Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
HUB INTERNATIONAL STRENGTHENS RETIREMENT AND WEALTH MANAGEMENT CAPABILITIES WITH THE ADDITION OF GOTTSCHLING BOOK OF BUSINESS
CHICAGO, Jan. 5, 2024 /PRNewswire/ — Hub International Limited (Hub), a leading global insurance brokerage and financial services firm, announced today that it has acquired the assets of Bob Gottschling’s book of business. Terms of the transaction were not disclosed. Based in Vienna, Virginia, Gottschling brings a wealth of experience including advanced personal retirement, investment and… Continue reading HUB INTERNATIONAL STRENGTHENS RETIREMENT AND WEALTH MANAGEMENT CAPABILITIES WITH THE ADDITION OF GOTTSCHLING BOOK OF BUSINESS
AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024
IRVINE, Calif., Jan. 5, 2024 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chief executive officer Hans S. Keirstead, Ph.D. will present at Biotech Showcase 2024, taking place January 8-10 in San Francisco, California. Company Presentation: AIVITA Biomedical, Inc. – Dr. Hans Keirstead When: Monday, January… Continue reading AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024
Cerapedics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
WESTMINSTER, Colo., Jan. 5, 2024 /PRNewswire/ — Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, today announced that Valeska Schroeder, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference. The company presentation will take place on Monday, January 8, 2024, at 5:00 PM PST… Continue reading Cerapedics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ProfoundBio Announces Rinatabart Sesutecan FDA Fast Track Designation for Patients with Advanced Ovarian Cancer
SEATTLE, Jan. 5, 2024 /PRNewswire/ — ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rinatabart sesutecan (Rina-S; PRO1184), a folate receptor alpha (FRα) targeted ADC, for the treatment of patients with FRα-expressing high-grade serous or… Continue reading ProfoundBio Announces Rinatabart Sesutecan FDA Fast Track Designation for Patients with Advanced Ovarian Cancer
PEAK ROCK CAPITAL AFFILIATE SELLS PARAGON HEALTHCARE, INC. TO ELEVANCE HEALTH
Paragon doubles revenues and increases the number of infusion centers by 400% during Peak Rock’s ownership AUSTIN, Texas, Jan. 5, 2024 /PRNewswire/ — An affiliate of Peak Rock Capital (“Peak Rock”), a leading middle-market private investment firm, announced today it has signed a definitive agreement for the sale of Paragon Healthcare, Inc. (“Paragon” or the “Company”)… Continue reading PEAK ROCK CAPITAL AFFILIATE SELLS PARAGON HEALTHCARE, INC. TO ELEVANCE HEALTH
Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
—ARIKAYCE® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net Product Sales of Approximately $305.2 Million— —2024 Global ARIKAYCE Revenues Expected to be Between $340 Million and $360 Million, Reflecting Double-Digit Growth Compared to 2023— —Topline Data from the Phase 3 ASPEN Study of Brensocatib… Continue reading Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
Ball Bearing Market to Attain a Valuation of USD 148.3 billion by 2031: Transparency Market Research Study
WILMINGTON, Del., Jan. 4, 2024 /PRNewswire/ — New materials and solutions may drive future demands for environmentally friendly ball bearings. Using 3D printing to manufacture bearings could open up new possibilities for design and production for the ball bearing market in coming years. The global ball-bearing industry generated US$ 63.7 billion in 2022. A CAGR of… Continue reading Ball Bearing Market to Attain a Valuation of USD 148.3 billion by 2031: Transparency Market Research Study